SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-203511
Filing Date
2017-06-14
Accepted
2017-06-14 16:14:57
Documents
3
Period of Report
2017-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d405700d6k.htm 6-K 10308
2 EX-99.1 d405700dex991.htm EX-99.1 225188
3 GRAPHIC g405700ex991pg01.jpg GRAPHIC 27965
  Complete submission text file 0001193125-17-203511.txt   275054
Mailing Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB
Business Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB 44-123-544-3939
Summit Therapeutics plc (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0114
Type: 6-K | Act: 34 | File No.: 001-36866 | Film No.: 17911297
SIC: 2834 Pharmaceutical Preparations